GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2019-12-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 200
- Registration Number
- NCT00197067
- Locations
- 🇲🇿
GSK Investigational Site, Maputo, Mozambique
Study In Patients With Insulin Resistance
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 18
- Registration Number
- NCT00197132
- Locations
- 🇳🇱
GSK Clinical Trials Call Center, Nijmegen, Netherlands
Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1847
- Registration Number
- NCT00197288
- Locations
- 🇺🇸
GSK Investigational Site, Marshfield, Wisconsin, United States
Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-05-10
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 492
- Registration Number
- NCT00169572
- Locations
- 🇨🇳
GSK Investigational Site, Tao Yuan County, Taiwan
Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.
- Conditions
- Interventions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 64
- Registration Number
- NCT00169546
- Locations
- 🇬🇧
GSK Investigational Site, Manchester, Lancashire, United Kingdom
Dyslipidemia Study Investigating The Increase In "Good Cholesterol"
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2012-10-22
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 250
- Registration Number
- NCT00169559
- Locations
- 🇨🇦
GSK Investigational Site, Sainte-Foy, Quebec, Canada
Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 745
- Registration Number
- NCT00169442
- Locations
- 🇵🇭
GSK Investigational Site, Quezon CIty, Philippines
Rollover Study Of Lapatinib In Cancer Patients
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 31
- Registration Number
- NCT00169533
- Locations
- 🇮🇱
GSK Investigational Site, Tel Aviv, Israel
A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-01-10
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 689
- Registration Number
- NCT00169481
- Locations
- 🇩🇪
GSK Investigational Site, Hamburg, Germany
Evaluation Of Valaciclovir In Patients With Chickenpox
- Conditions
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 43
- Registration Number
- NCT00169416